Evidence map›Paper›PMID 39289350›Full record

Observational studyNature communications2024

DNA Methylation signatures underpinning blood neutrophil to lymphocyte ratio during first week of human life.

David Martino, Nina Kresoje, Nelly Amenyogbe, Rym Ben-Othman, Bing Cai, Mandy Lo, Olubukola Idoko, Oludare A Odumade, Reza Falsafi, Travis M Blimkie and 18 more

Abstract readObservational Study
In one paragraph

Observational study in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Immune development in early life.Nature immunology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

David MartinoThe Kids Research Institute Australia, Perth, WA, Australia. david.martino@thekids.org.au.ORCID 0000-0001-6823-4696
Nina KresojeThe Kids Research Institute Australia, Perth, WA, Australia.
Nelly AmenyogbeThe Kids Research Institute Australia, Perth, WA, Australia.
Rym Ben-OthmanRAN BioLinks Ltd, Ontario, Canada.
Bing CaiBC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
Mandy LoBC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
Olubukola IdokoVaccines & Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Banjul, Gambia.
Oludare A OdumadePrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
Reza FalsafiDepartment of Microbiology & Immunology, University of British Columbia, Vancouver, BC, Canada.
Travis M BlimkieDepartment of Microbiology & Immunology, University of British Columbia, Vancouver, BC, Canada.
Andy AnDepartment of Microbiology & Immunology, University of British Columbia, Vancouver, BC, Canada.
Casey P ShannonPROOF Centre of Excellence, Providence Research, Vancouver, BC, Canada.ORCID 0000-0002-5687-3156
Sebastiano MontanteBC Cancer Agency, Vancouver, BC, Canada.
Bhavjinder K DhillonDepartment of Microbiology & Immunology, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-9696-1556
Joann Diray-ArcePrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0003-2183-4269
Al OzonoffPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0003-4233-5899
Kinga K SmolenPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0001-8650-3693
Ryan R BrinkmanBC Cancer Agency, Vancouver, BC, Canada.
Kerry McEnaneyPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0002-0378-3456
Asimenia AngelidouPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0002-6716-6561
Peter RichmondThe Kids Research Institute Australia, Perth, WA, Australia.
Scott J TebbuttPROOF Centre of Excellence, Providence Research, Vancouver, BC, Canada.ORCID 0000-0002-7908-1581
EPIC-HIPC consortium
Beate KampmannVaccines & Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Atlantic Boulevard, Banjul, Gambia.
Ofer LevyPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0002-5859-1945
Robert E W HancockDepartment of Microbiology & Immunology, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-5989-8503
Amy H Y LeeMolecular Biology & Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
Tobias R KollmannThe Kids Research Institute Australia, Perth, WA, Australia.ORCID 0000-0003-2403-9762

Funding

Transcriptomics to define biomarkers of neonatal vaccine immunogenicityU19AI118608 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2017 to 2021
$24.7M
Proteomics and Metabolomics Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthmaU19AI168643 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI OFER LEVY · 2022 to 2026
$10.0M
Immunometabolic signatures of BCG-induced neonatal trained immunityK08AI168487 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Asimenia Angelidou · 2023 to 2026
$704k
NIAID NIH HHS K08 AI168487NIAID NIH HHS U19 AI118608NIAID NIH HHS U19 AI168643U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) 1K08AI168487U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI118608U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI168643
6 · The paper itself

Abstract

Understanding of newborn immune ontogeny in the first week of life will enable age-appropriate strategies for safeguarding vulnerable newborns against infectious diseases. Here we conducted an observational study exploring the immunological profile of infants longitudinally throughout their first week of life. Our Expanded Program on Immunization - Human Immunology Project Consortium (EPIC-HIPC) studies the epigenetic regulation of systemic immunity using small volumes of peripheral blood samples collected from West African neonates on days of life (DOL) 0, 1, 3, and 7. Genome-wide DNA methylation and single nucleotide polymorphism markers are examined alongside matched transcriptomic and flow cytometric data. Integrative analysis reveals that a core network of transcription factors mediates dynamic shifts in neutrophil-to-lymphocyte ratios (NLR), which are underpinned by cell-type specific methylation patterns in the two cell types. Genetic variants are associated with lower NLRs at birth, and healthy newborns with lower NLRs at birth are more likely to subsequently develop sepsis. These findings provide valuable insights into the early-life determinants of immune system development.

Indexed as

DNA MethylationLymphocytesNeutrophilsPolymorphism, Single NucleotideEpigenesis, GeneticFemaleHumansInfant, NewbornMale

Identifiers

PMID39289350
PMCPMC11408723

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.